Lux Capital

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Lux Capital is a venture capital firm founded by Peter Hébert, Robert Paull, and Josh Wolfe[1] in 2000[2] . The firm, based in New York City with an office in Menlo Park, invests in emerging technologies in the physical and life sciences.[3][4]

Lux Capital
Private
Industry Venture capital
Founded 2000
Founders Peter Hébert
Robert Paull
Josh Wolfe
Headquarters New York, NY, Menlo Park, CA, United States
Total assets $700,000,000
Website luxcapital.com

About[edit]

Lux Capital is a venture firm based in New York City and Silicon Valley investing in counter-conventional, seed and early stage science and technology ventures. The firm manages $700 million in assets across four funds.[5] Lux founded strategic holdings in media, research and policy as proprietary sources of intelligence, access and influence – ensuring that portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competition.The Lux Capital team has built more than 20 companies from scratch.[5]

In April 2011, former McKinsey Senior Partner Richard N. Foster and former CIA Director James Woolsey joined Lux Capital as venture partners.[6] In August 2012, former Pfizer Chairman and CEO Jeff Kindler joined Lux Capital as a venture partner.[7]

Portfolio companies[edit]

  • 3Scan
  • AltspaceVR
  • BrightSky Labs
  • Cambrios
  • CloudMedx Inc
  • Cerulean Pharma [NASDAQ:CERU]
  • Crystal IS
  • CyPhy Works
  • Echodyne
  • Everspin Technologies
  • Experiment
  • Genocea Biosciences [NASDAQ:GNCA]
  • Gridco
  • Halo Neuroscience
  • Kala Pharmaceuticals
  • Kurion
  • Kymeta
  • Kyruus
  • Lensbricks
  • Luxtera
  • Matterport
  • Moment
  • Nanosys
  • Orbital Insight
  • Pager
  • Plethora
  • Planet Labs
  • Nanosys
  • Nervana Systems
  • Scaled Inference
  • Siluria Technologies
  • Sols
  • Transphorm
  • Visterra
  • Vium

See also[edit]

References[edit]

  1. ^ Fickenscher, Lisa (2003). "2003 40 Under 40". Crain's New York Business. Jan 27 - Feb 2, 2003: 15–31. ISSN 8756-789X. OCLC 11620213. 
  2. ^ Eden, Scott (2009). "Nano Wunderkinds". Dealmaker. December/January 2009: 35–37. ISSN 1937-304X. OCLC 132936538. 
  3. ^ Kosoff, Maya (2 April 2015). "Venture firm Lux just got $350 million more to invests in robots, the future, and science". Business Insider. Retrieved 8 June 2015. 
  4. ^ de la Merced, Michael (2 April 2015). "Lux Capital Raises $350 Million Fund to Back Science Start-Ups". New York Times. Retrieved 8 June 2015. 
  5. ^ a b "Our Story". Lux Website. 14 June 2015. 
  6. ^ "James Woolsey and Richard Foster Join Lux Capital as Venture Partners". Business Wire. 26 April 2011. 
  7. ^ "Kindler, Former Pfizer Chief, Joins Lux Capital". Dealbook. 8 August 2012. 

External links[edit]